Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology

British Journal of Clinical Pharmacology

Volumn 83, Issue 1, 2017, Pages 54-62

  Pantano, Daniela ^a   Luccarini, Ilaria ^a   Nardiello, Pamela ^a   Servili, Maurizio ^c   Stefani, Massimo ^b   Casamenti, Fiorella ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Alzheimer's disease; amyloid plaques; authophagy; memory function; oleuropein aglycone; olive polyphenols

Indexed keywords

ACTEOSIDE; AGLYCONE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; HYDROXYTHYROSOL; NEUROPROTECTIVE AGENT; OLE DI ALDEHYDE; OLEUROPEIN; OLEUROPEIN AGLYCONE; OLIVE OIL; POLYPHENOL DERIVATIVE; THYROSOL; UNCLASSIFIED DRUG; AMYLOID BETA-PROTEIN (1-42); AMYLOID PRECURSOR PROTEIN; IRIDOID; PEPTIDE FRAGMENT; POLYPHENOL;

AIN 76 A DIET; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOPHAGY; AVOIDANCE BEHAVIOR; BRAIN CORTEX; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOSE RESPONSE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LOW FAT DIET; MOUSE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OLIVE; OLIVE MILL WASTE WATER; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; TREATMENT DURATION; WASTE WATER; AMYLOID PLAQUE; ANIMAL; BRAIN; CHEMISTRY; DIETARY SUPPLEMENT; DISEASE MODEL; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; OLIVE TREE; PATHOLOGY;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COGNITIVE DYSFUNCTION; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IRIDOIDS; MICE, TRANSGENIC; OLEA; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; POLYPHENOLS; WASTE WATER;

EID: 84971247385     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12993     Document Type: Review

References (46)

1. Haass C. Take five–BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 2004; 23: 483–8.
2. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003; 43: 545–84.
3. Hayden EY, Teplow DB. Amyloid beta-protein oligomers and Alzheimer's disease. Alzheimers Res Ther 2013; 5: 60.
4. Cheng B, Gong H, Xiao H, Petersen RB, Zheng L, Huang K. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim Biophys Acta 1830; 2013: 4860–71.
5. Gazit E. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J 2002; 16: 77–83.
6. Kolstoe SE, Mangione PP, Bellotti V, Taylor GW, Tennent GA, Deroo S, et al. Trapping of palindromic ligands within native transthyretin prevents amyloid formation. Proc Natl Acad Sci U S A 2010; 107: 20483–8.
7. Giorgetti S, Raimondi S, Pagano K, Relini A, Bucciantini M, Corazza A, et al. Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils. J Biol Chem 2011; 286: 2121–31.
8. Stefani M, Rigacci S. Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation. Biofactors 2014; 40: 482–93.
9. Ahmad E, Ahmad A, Singh S, Arshad M, Khan AH, Khan RH. A mechanistic approach for islet amyloid polypeptide aggregation to develop anti-amyloidogenic agents for type-2 diabetes. Biochimie 2011; 93: 793–805.
10. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006; 59: 912–21.
11. Scarmeas N, Luchsinger JA, Stern Y, Gu Y, He J, DeCarli C, et al. Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol 2011; 69: 257–68.
12. Feart C, Samieri C, Barberger-Gateau P. Mediterranean diet and cognitive function in older adults. Curr Opin Clin Nutr Metab Care 2010; 13: 14–8.
13. Feart C, Samieri C, Alles B, Barberger-Gateau P. Potential benefits of adherence to the Mediterranean diet on cognitive health. Proc Nutr Soc 2013; 72: 140–52.
14. Rigacci S, Guidotti V, Bucciantini M, Nichino D, Relini A, Berti A, et al. Abeta(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. Curr Alzheimer Res 2011; 8: 841–52.
15. Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A. Olive-oil-derived oleocanthal enhances beta-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies. ACS Chem Neurosci 2013; 4: 973–82.
16. Monti MC, Margarucci L, Riccio R, Casapullo A. Modulation of tau protein fibrillization by oleocanthal. J Nat Prod 2012; 75: 1584–8.
17. Tangney CC, Kwasny MJ, Li H, Wilson RS, Evans DA, Morris MC. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am J Clin Nutr 2011; 93: 601–7.
18. Feart C, Samieri C, Rondeau V, Amieva H, Portet F, Dartigues JF, et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009; 302: 638–48.
19. Pitozzi V, Jacomelli M, Zaid M, Luceri C, Bigagli E, Lodovici M, et al. Effects of dietary extra-virgin olive oil on behaviour and brain biochemical parameters in ageing rats. Br J Nutr 2010; 103: 1674–83.
20. Valls-Pedret C, Lamuela-Raventos RM, Medina-Remon A, Quintana M, Corella D, Pintó X, et al. Polyphenol-rich foods in the Mediterranean diet are associated with better cognitive function in elderly subjects at high cardiovascular risk. J Alzheimers Dis 2012; 29: 773–82.
21. Pitt J, Roth W, Lacor P, Smith AB 3rd, Blankenship M, Velasco P, et al. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol Appl Pharmacol 2009; 240: 189–97.
22. Servili M, Selvaggini R, Esposto S, Taticchi A, Montedoro G, Morozzi G. Health and sensory properties of virgin olive oil hydrophilic phenols: agronomic and technological aspects of production that affect their occurrence in the oil. J Chromatogr A 2004; 1054: 113–27.
23. Rigacci S, Guidotti V, Bucciantini M, Parri M, Nediani C, Cerbai E, et al. Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. J Nutr Biochem 2010; 21: 726–35.
24. Daccache A, Lion C, Sibille N, Gerard M, Slomianny C, Lippens G, et al. Oleuropein and derivatives from olives as Tau aggregation inhibitors. Neurochem Int 2011; 58: 700–7.
25. Diomede L, Rigacci S, Romeo M, Stefani M, Salmona M. Oleuropein aglycone protects transgenic C. elegans strains expressing Aβ 42 by reducing plaque load and motor deficit. PLoS One 2013; 8: e58893.
26. Grossi C, Rigacci S, Ambrosini S, Ed Dami T, Luccarini I, Traini C, et al. The polyphenol oleuropein aglycone protects TgCRND8 mice against Aβ plaque pathology. PLoS One 2013; 8: e71702.
27. Luccarini I, Grossi C, Rigacci S, Coppi E, Pugliese AM, Pantano D, et al. Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ss toxicity: biochemical, epigenetic and functional correlates. Neurobiol Aging 2015; 36: 648–63.
28. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 2001; 276: 21562–70.
29. Masi F, Bresciani R, Munz G, Lubello C. Evaporation-condensation of olive mill wastewater: evaluation of condensate treatability through SBR and constructed Wetlands. Ecol Eng 2015; 80: 156–61.
30. Servili M, Rizzello CG, Taticchi A, Esposto S, Urbani S, Mazzacane F, et al. Functional milk beverage fortified with phenolic compounds extracted from olive vegetation water, and fermented with functional lactic acid bacteria. Int J Food Microbiol 2011; 147: 45–52.
31. Konno K, Hirayama C, Yasui H, Nakamura M. Enzymatic activation of oleuropein: a protein crosslinker used as a chemical defense in the privet tree. Proc Natl Acad Sci U S A 1999; 96: 9159–64.
32. Bellucci A, Luccarini I, Scali C, Prosperi C, Giovannini MG, Pepeu G, et al. Cholinergic Dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol Dis 2006; 23: 260–72.
33. Bartolini L, Casamenti F, Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav 1996; 53: 277–83.
34. Hammond RS, Tull LE, Stackman RW. On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 2004; 82: 26–34.
35. Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, et al. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 2010; 19: 1155–67.
36. Fiorentini A, Rosi MC, Grossi C, Luccarini I, Casamenti F. Lithium improves hippocampal neurogenesis, neuropathology and cognitive functions in APP mutant mice. PLoS One 2010; 5: e14382.
37. Grossi C, Francese S, Casini A, Rosi MC, Luccarini I, Fiorentini A, et al. Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 2009; 17: 423–40.
38. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates, Second edn. London UK: Academic Press, 2001.
39. Potočnjak I, Škoda M, Pernjak-Pugel E, Peršić MP, Domitrović R. Oral administration of oleuropein attenuates cisplatin-induced acute renal injury in mice through inhibition of ERK signaling. Mol Nutr Food Res 2016; 60: 530–41.
40. Drira R, Chen S, Sakamoto K. Oleuropein and hydroxytyrosol inhibit adipocyte differentiation in 3 T3-L1 cells. Life Sci 2011; 89: 708–16.
41. Turner RS, Thomas RG, Craft S, van Dyck CH, Mintzer J, Reynolds BA, et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 2015; 85: 1383–91.
42. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly) phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013; 18: 1818–92.
43. Rigacci S, Stefani M. Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols. Expert Rev Neurother 2015; 15: 41–52.
44. Rudinskiy N, Hawkes JM, Betensky RA, Eguchi M, Yamaguchi S, Spires-Jones TL, et al. Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease. Nat Neurosci 2012; 15: 1422–9.
45. Grienberger C, Rochefort NL, Adelsberger H, Henning HA, Hill DN, Reichwald J, et al. Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease. Nat Commun 2012; 3: 774.
46. Sperling RA, Laviolette PS, O'Keefe K, O'Brien J, Rentz DM, Pihlajamaki M, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009; 63: 178–88.